
|Articles|February 2, 2002
Derms must avoid prescribing out of habit
Being critical of existing therapies, willing to embrace new approachesequals success
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
2
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
3
Introducing Dermatology Times NP/PA Connect
4
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
5











